<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://insight4mds.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.9.2" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.4" --><!-- generated-on="August 10, 2010 8:11 am" --><!-- Debug: Total comment count: 7 --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://insight4mds.com/</loc>
		<lastmod>2010-08-10T15:09:23+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings --><!-- Debug: Priority report of postID 3159: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/liraglutide-effect-and-action-in-diabetes-lead-2-effect-on-glycaemic-control-after-once-daily-administration-of-liraglutide-in-combination-with-metformin-versus-metformin-monotherapy-versus-metform/</loc>
		<lastmod>2010-08-10T15:09:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3215: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-double-blind-placebo-and-active-controlled-randomized-study-to-evaluate-the-safety-and-efficacy-of-the-addition-of-sitagliptin-100-mg-once-daily-in-patients-with-type-2-diabetes-with/</loc>
		<lastmod>2010-08-02T22:56:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3226: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-placebo-controlled-phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-saxagliptin-bms477118-in-combination-with-thiazolidinedione-therapy-in-subjects-wi/</loc>
		<lastmod>2010-08-02T22:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3231: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-placebo-controlled-phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-bms-477118-in-combination-with-metformin-in-subjects-with-type-2-diabetes-who-have-i/</loc>
		<lastmod>2010-08-02T22:54:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3235: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-placebo-controlled-phase-3-trial-to-evaluate-the-efficacy-and-safety-of-saxagliptin-as-monotherapy-with-titration-in-subjects-with-type-2-diabetes-who-have-in/</loc>
		<lastmod>2010-08-02T22:53:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3245: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-placebo-controlled-phase-3-trial-to-evaluate-the-efficacy-and-safety-of-saxagliptin-in-combination-with-glyburide-in-subjects-with-type-2-diabetes-who-have-inad/</loc>
		<lastmod>2010-08-02T22:52:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3283: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/the-persistent-trial-a-prospective-randomized-trial-comparing-insulin-lispro-protamine-suspension-to-insulin-glargine-in-patients-with-type-2-diabetes-on-anti-hyperglycemic-medications/</loc>
		<lastmod>2010-08-02T22:50:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3289: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/treat-to-target-comparison-of-two-basal-insulin-analogs-insulin-lispro-protamine-suspension-and-comparator-in-basal-therapy-for-patients-with-type-2-diabetes-mellitus/</loc>
		<lastmod>2010-08-02T22:49:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3303: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-phase-4-randomized-open-label-parallel-group-multicenter-study-to-characterize-regimens-of-basal-insulin-intensified-with-either-symlin%c2%ae-or-rapid-acting-insulin-in-patients-with-type-2-diab/</loc>
		<lastmod>2010-08-02T22:48:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3316: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/comparison-of-two-therapeutic-strategies-for-treating-type-2-diabetic-patients-poorly-controlled-with-basal-insulin-associated-with-oral-antidiabetic-drugs-6-month-proof-of-concept-study/</loc>
		<lastmod>2010-08-02T22:47:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3597: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/liraglutide-effect-and-action-in-diabetes-lead-5-effect-on-glycaemic-control-after-once-daily-administration-of-liraglutide-in-combination-with-glimepiride-and-metformin-versus-glimepiride-and-metf/</loc>
		<lastmod>2010-08-02T22:46:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3669: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/3-year-efficacy-and-safety-comparison-of-adding-insulin-detemir-biphasic-insulin-aspart-30-or-insulin-aspart-to-oral-antidiabetic-drug-treatment-in-type-2-diabetes/</loc>
		<lastmod>2010-08-02T22:44:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3673: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/an-18-week-international-multi-centre-randomized-parallel-group-double-blind-active-controlled-phase-iiib-study-to-evaluate-the-efficacy-and-safety-of-saxagliptin-in-combination-with-metformin-i/</loc>
		<lastmod>2010-08-02T22:44:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3705: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-randomized-open-label-multicenter-comparator-controlled-study-to-examine-the-effects-of-exenatide-long-acting-release-on-glucose-control-hba1c-and-safety-in-subjects-with-type-2-diabetes-mellit/</loc>
		<lastmod>2010-08-02T22:43:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3737: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/effect-of-liraglutide-on-glycaemic-control-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-08-02T22:42:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3821: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-six-month-open-label-randomized-parallel-group-trial-assessing-the-impact-of-dry-powder-inhaled-insulin-exubera-on-glycemic-control-compared-to-insulin-glargine-lantus-in-patients-with-type-2-diabet/</loc>
		<lastmod>2010-08-02T22:41:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3837: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-randomized-open-label-multicenter-study-assessing-the-effects-of-forced-exubera-dose-titration-on-glycemic-control-in-patients-with-suboptimally-controlled-type-2-diabetes-on-two-or-more-oral-anti/</loc>
		<lastmod>2010-08-02T22:39:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3210: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-double-blind-randomized-placebo-controlled-study-of-mk0431-in-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control/</loc>
		<lastmod>2010-08-02T22:33:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3205: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-factorial-study-of-the-co-administration-of-mk0431-and-metformin-in-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control/</loc>
		<lastmod>2010-08-02T22:33:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3200: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-the-addition-of-mk0431-to-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-c/</loc>
		<lastmod>2010-08-02T22:32:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3191: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-double-blind-randomized-study-to-evaluate-the-safety-and-efficacy-of-the-addition-of-mk-0431-compared-with-sulfonylurea-therapy-in-patients-with-type-2-diabetes-with-inadequate-glycemi/</loc>
		<lastmod>2010-08-02T22:31:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3182: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-study-to-evaluate-the-safety-and-efficacy-of-mk0431-monotherapy-in-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control/</loc>
		<lastmod>2010-08-02T22:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3176: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-study-to-evaluate-the-safety-and-efficacy-of-the-addition-of-mk-0431-to-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control-on-pioglitaz/</loc>
		<lastmod>2010-08-02T22:30:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3139: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/an-open-label-study-to-examine-the-long-term-effect-on-glucose-control-hba1c-and-safety-and-tolerability-of-exenatide-given-two-times-a-day-to-subjects-with-type-2-diabetes-mellitus/</loc>
		<lastmod>2010-08-02T22:27:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3124: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/an-open-label-study-comparing-exenatide-with-basal-insulin-in-achieving-an-hba1c-of-%e2%89%a4-74-with-minimum-weight-gain-in-type-2-diabetes-patients-who-are-not-achieving-adequate-hba1c-control-on-2/</loc>
		<lastmod>2010-08-02T22:26:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3116: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/a-phase-4-multicenter-randomized-double-blind-cross-over-study-to-compare-the-effects-of-exenatide-and-sitagliptin-on-postprandial-glucose-control-in-subjects-with-type-2-diabetes-mellitus-inadequ/</loc>
		<lastmod>2010-08-02T22:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3099: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/an-open-label-study-comparing-exenatide-with-basal-insulin-in-achieving-an-hba1c-of-%e2%89%a4-74-with-minimum-weight-gain-in-type-2-diabetes-patients-who-are-not-achieving-adequate-hba1c-control-on/</loc>
		<lastmod>2010-08-02T22:23:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3624: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/efficacy-of-exenatide-ac2993-synthetic-exendin-4-ly2148568-compared-with-twice-daily-biphasic-insulin-aspart-in-patients-with-type-2-diabetes-using-sulfonylurea-and-metformin/</loc>
		<lastmod>2010-08-02T22:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3740: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/effect-of-liraglutide-in-combination-with-sulfonylurea-su-on-glycaemic-control-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-07-30T02:15:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3744: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/effect-of-liraglutide-or-glimepiride-added-to-metformin-on-glycaemic-control-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-07-30T02:10:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3829: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-six-month-open-label-outpatient-randomized-parallel-group-trial-assessing-the-impact-of-dry-powder-inhaled-insulin-exubera%c2%ae-on-glycemic-control-compared-to-insulin-glargine-lantus%c2%ae-i/</loc>
		<lastmod>2010-07-30T02:02:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3843: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/target-glycemic-control-and-the-incidence-of-documented-symptomatic-hypoglycemia-in-insulin-naive-subjects-with-type-2-diabetes-failing-on-oral-hypoglycemic-agents-and-treated-with-insulin-glargine/</loc>
		<lastmod>2010-07-30T01:58:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3220: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-placebo-controlled-phase-3-trial-to-evaluate-the-efficacy-and-safety-of-saxagliptin-bms-477118-as-monotherapy-in-subjects-with-type-2-diabetes-who-have-inad/</loc>
		<lastmod>2010-07-30T01:19:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3240: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-multicenter-randomized-double-blind-active-controlled-phase-3-trial-to-evaluate-the-efficacy-and-safety-of-saxagliptin-in-combination-with-metformin-ir-as-initial-therapy-compared-to-saxagliptin/</loc>
		<lastmod>2010-07-30T00:51:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3252: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/safety-and-efficacy-of-biphasic-insulin-aspart-7030-novolog%c2%ae-mix-7030-vs-exenatide-byettatm-in-subjects-with-type-2-diabetes-mellitus-not-achieving-glycemic-targets-on-metformin-and-a-sulf/</loc>
		<lastmod>2010-07-30T00:12:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3258: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/comparison-of-the-effect-on-glycemic-control-of-biphasic-insulin-aspart-7030-versus-insulin-glargine-in-combination-with-metformin-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-07-30T00:05:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3309: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/28-week-open-randomized-multinational-multicenter-clinical-trial-to-compare-efficacy-and-safety-of-combination-therapy-of-glimepiride-plus-metformin-plus-hoe901-insulin-analogue-versus-a-two-inj/</loc>
		<lastmod>2010-07-29T23:41:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3609: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/effect-on-glycemic-control-of-liraglutide-in-combination-with-rosiglitazone-plus-metformin-versus-rosiglitazone-plus-metformin-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-07-28T15:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3628: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/a-phase-2-randomized-double-blind-placebo-controlled-multicenter-study-to-examine-safety-and-pharmacokinetics-of-exenatide-long-acting-release-administered-weekly-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-07-28T15:54:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3696: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/44-week-parallel-open-randomized-multinational-multi-center-clinical-trial-to-compare-efficacy-and-safety-of-the-combination-therapy-of-an-oral-anti-diabetic-drug-treatment-with-either-hoe901-ins-2/</loc>
		<lastmod>2010-07-28T15:42:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3152: Comments: 0 of 7 = 0 points -->	<url>
		<loc>http://insight4mds.com/liraglutide-effect-and-action-in-diabetes-lead-1-effect-on-glycaemic-control-after-once-daily-administration-of-liraglutide-in-combination-with-glimepiride-versus-glimepiride-monotherapy-versus-gli/</loc>
		<lastmod>2010-07-24T16:08:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3165: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/liraglutide-effect-and-action-in-diabetes-lead-3-effect-on-glycemic-control-of-liraglutide-versus-glimepiride-in-type-2-diabetes/</loc>
		<lastmod>2010-07-24T15:57:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3169: Comments: 1 of 7 = 0.1 points -->	<url>
		<loc>http://insight4mds.com/effect-of-liraglutide-or-exenatide-added-to-a-background-treatment-of-metformin-sulphonylurea-or-a-combination-of-both-on-glycaemic-control-in-subjects-with-type-2-diabetes/</loc>
		<lastmod>2010-07-24T15:52:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/victoza-pen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:37:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/victoza-liraglutide-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:36:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/type-1-diabetes-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:36:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/tour/</loc>
		<lastmod>2010-06-02T15:34:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/symlinpen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:30:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/symlin-pramlintide-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:30:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/sulfonylureas-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:29:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/solostar-pen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:29:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/sign-in/</loc>
		<lastmod>2010-06-02T15:28:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/sanofi-aventis-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:27:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/register-medical-doctors/</loc>
		<lastmod>2010-06-02T15:27:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/pfizer-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:26:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/optiset-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:25:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/onglyza-saxagliptin-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:25:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/nph-insulin-7030-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:24:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/novonordisk-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:23:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/novolog-mix-7030-biasp-7030-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:23:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/novolog-insulin-aspart-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:22:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/niddk-nih-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:21:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/metformin-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:21:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/merck-co-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:20:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/basic-membership-for-medical-doctors/</loc>
		<lastmod>2010-06-02T15:19:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/membership/non-member/</loc>
		<lastmod>2010-06-02T15:18:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/membership/</loc>
		<lastmod>2010-06-02T15:17:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/medical-doctors-home/</loc>
		<lastmod>2010-06-02T15:16:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/logo/</loc>
		<lastmod>2010-06-02T15:08:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/levemir-insulin-detemir-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:07:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/lantus-insulin-glargine-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:06:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/kwikpen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:06:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/januvia-sitagliptin-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:05:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/insulin-pump-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:05:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/insulin-lispro-protamine-suspension-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:04:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/insulin-not-specified-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:04:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/humalog-pen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:03:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/humalog-insulin-lispro-clinical-trial-results/</loc>
		<lastmod>2010-06-02T15:02:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/footer/terms-and-conditions/</loc>
		<lastmod>2010-06-02T15:01:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/footer/privacy-policy/</loc>
		<lastmod>2010-06-02T14:47:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/footer/</loc>
		<lastmod>2010-06-02T14:45:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/flexpen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:44:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/exubera-inhaler-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:44:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/exubera-inhaled-insulin-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:43:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/eli-lilly-and-company-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:43:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/medical-doctors-contact/</loc>
		<lastmod>2010-06-02T14:42:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/byetta-pen-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:41:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/byetta/</loc>
		<lastmod>2010-06-02T14:41:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/bristol-myers-squibb-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:40:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/avandia-rosiglitazone-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:40:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/astrazeneca-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:39:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/apidra-insulin-glulisine-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:39:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/amylin-pharmaceuticals-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:38:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/actos-pioglitazone-clinical-trial-results/</loc>
		<lastmod>2010-06-02T14:38:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/contact/press-contact/</loc>
		<lastmod>2009-05-08T00:03:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://insight4mds.com/wishlist-member/</loc>
		<lastmod>2009-04-08T02:58:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings --><!-- Debug: Start Custom Pages --><!-- Debug: End Custom Pages --><!-- Debug: Start additional URLs --><!-- Debug: End additional URLs --></urlset>
